Dogwood Therapeutics
DWTX
24 hedge funds and large institutions have $1.08M invested in Dogwood Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
251% more capital invested
Capital invested by funds: $307K → $1.08M (+$771K)
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
4% more funds holding
Funds holding: 23 → 24 (+1)
0.32% less ownership
Funds ownership: 4.58% → 4.27% (-0.32%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$217K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$99.3K |
| 3 |
State Street
Boston,
Massachusetts
|
+$48.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$38K |
| 5 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
+$35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$125K |
| 2 |
BlackRock
New York
|
-$45.5K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$44.3K |
| 4 |
PAM
PVG Asset Management
Golden,
Colorado
|
-$29.6K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$27.5K |
DWTX Hedge Fund Activity: Q2 2023 in Review
24 of the 6,384 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q2 2023, worth a combined $1.08M — up 251% from $307K a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new DWTX positions and 7 closed out — a net gain of 1 holder — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $217K. The largest seller was Susquehanna International Group, cutting an estimated $125K.
- 24 institutional investors held Dogwood Therapeutics (DWTX) as of Q2 2023, up from 23 in Q1 2023.
- Funds reported $1.08M of Dogwood Therapeutics stock for Q2 2023, up 251% quarter-over-quarter.
- 8 funds opened new Dogwood Therapeutics positions in Q2 2023 and 7 closed out, a net change of +1 holder.
- The largest Dogwood Therapeutics buyer in Q2 2023 was Vanguard Group, an estimated $217K added.
- The largest Dogwood Therapeutics seller in Q2 2023 was Susquehanna International Group, an estimated $125K sold.
Based on aggregated 13F filings for Q2 2023.